Brooks sues Puma in running-shoe patent dispute
By Blake Brittain
Sept 24 (Reuters) -Berkshire Hathaway's BRKa.N Brooks Sports sued German shoemaker Puma PUMG.DE in Virginia federal court on Tuesday in the latest salvo in an ongoing intellectual property dispute between the rivals.
Brooks said in its lawsuit that Puma had threatened to sue it for infringing a patent covering a type of ridged shoe sole, and asked the court to determine that its Glycerin running shoes do not violate Puma's rights.
Puma said in a statement that it is "committed to protecting and defending our intellectual property rights" and "look[s] forward to presenting our case." Seattle-based Brooks said in a statement that Puma's accusations are "the latest in a series of groundless allegations Puma has made against Brooks."
Puma first sued Brooks in 2022, arguing that Brooks' advertising for sneakers with nitrogen-infused soles violated its "Nitro" trademark rights. That case is still ongoing.
Puma also filed a separate patent lawsuit against Brooks in June over its Hyperion running shoes.
Brooks said in its complaint on Tuesday that Puma's "wrongful" allegations over its Glycerin 21 shoes "caused and will continue to cause Brooks irreparable injury and damage."
The case is Brooks Sports Inc v. Puma SE, U.S. District Court for the Eastern District of Virginia, No. 3:24-cv-00668.
For Brooks: Aaron Parker, Elizabeth Ferrill and Sonja Sahlsten of Finnegan Henderson Farabow Garrett & Dunner
For Puma: attorney information not yet available
Read more:
Puma accuses Brooks of infringing 'Nitro' running shoe trademark
Reporting by Blake Brittain in Washington
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
